Harrington Robert Arthur bought CYTK
October 15, 2025 · Form 4 insider transaction
Harrington Robert Arthur bought 199 shares of Cytokinetics, Incorporated at $62.80 per share, a transaction worth $12.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
199
Price
$62.80
Total value
$12.5K
InsiderHarrington Robert Arthur
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 15, 2025
Filing dateOctober 16, 2025
Shares owned after20,692
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Director equity in lieu of cash retainer program.